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Introduction
Posterior reversible encephalopathy syndrome (PRES) is a
distinct clinical entity presenting with a constellation of
neurological symptoms and characteristic neuroimaging
findings of posterior cerebral white matter edema. In
adults, PRES has been associated with a variety of condi-
tions and predisposing factors, including acute hyperten-
sion, preeclampsia or eclampsia, renal disease, sepsis, and
exposure to immunosuppressants. The syndrome has
been reported less frequently in children, with only one
publication reporting the association of PRES with
macrophage activation syndrome (MAS) in a patient with
systemic onset juvenile idiopathic arthritis (SoJIA).
Objectives
We report a case of newly diagnosed SoJIA complicated





A newly diagnosed 8-year-old boy with SoJIA left the
hospital on prednizolone (1 mg/kg p.o.), in order to re-
examined after 10 days. At that time, he appeared with
hemoglobin 104 g/L, leukocytes 17.44x109/L, platelets
406x109/L, ESR 120 mm and serum ferritin 1050 μg/L.
One week later and despite his gradual clinical improve-
ment, he re-admitted because he presented persistent
high grade fever and rash. On re-admission, laboratory
results have shown hemoglobin 96 g/L, leukocytes
5.60x109/L, platelets 208x109/L, ESR 60 mm, serum ferri-
tin 7500 μg/L, fibrinogen 1.23 g/L, LDH 1526 U/L and
triglycerides 582 mg/dL. With the tentative diagnosis of
MAS the patient administered prednisolone pulses and
cyclosporine (75 mg x 2 / day). His clinical picture and
laboratory findings were rapidly improved but, on the
fifth day from the initiation of treatment, elevation the
blood pressure was appeared and tapering of predniso-
lone and cyclosporine was started. The day after, the
patient presented tonic-clonic seizures that necessitated
his admission in the intensive care unit for two days.
Axial T2-w and FLAIR MRI images demonstrated char-
acteristic of PRES, bilateral and symmetrical high signal
intensity lesions involving cortical and subcortical areas
of the posterior part of the hemispheres. Prednizolone
and cyclosporine discontinued, and the neurological syn-
drome was completely controlled with antihypertensives
and antiepileptics. Two weeks later the patient left the
hospital on anakinra, prednisolone (1 mg/kg p.o.) and
antiepileptics. After six months, prednisolone has been
discontinued and the patient is free of inflammatory
symptoms but any attempt to discontinue antiepileptics
leads to the relapse of seizures. However, follow up MRI
showed complete resolution of previously noted abnor-
mal signal of PRES lesions.
Conclusion
Approximately 30% of pediatric patients with MAS
complicating autoimmune diseases present with neuro-
logical manifestations mimicking those of PRES (head-
aches, seizures, etc.). Therefore, a possible association of
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MAS with PRES imposes awareness towards prompt
radiological examination that will facilitate the early
recognition of the last condition and the timely institu-
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